Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFenner PLC Regulatory News (FENR)

  • There is currently no data for FENR

Trading Update

22 Jul 2015 07:00

RNS Number : 7027T
Fenner PLC
22 July 2015
 

22 July 2015

Fenner PLC

("Fenner" or "the Group")

 

Trading Update

 

Fenner presents its scheduled trading update covering the period since the end of the first half of its financial year on 28 February 2015.

During the period, AEP's industrial, medical and other non-oil businesses, which represent more than two-thirds of AEP's revenue, continued to perform well as a result of stronger demand and new business wins. Secant Medical has completed the first phase of its major facility consolidation as planned and integration of Charter Medical is proceeding on schedule.

AEP's principal businesses serving the oil/gas sector experienced reduced order intake from February which, as anticipated, impacted trading results from April onwards to an extent consistent with movements in industry metrics. Demand for Mandals hoses used in hydraulic fracturing has remained at very low levels.

Demand levels for ECS products and services in North America are reflecting sequentially lower production levels in the coal mining industry, the impact of which is being partially offset by good progress and generally improving demand from the bulk materials sector. In APAC, ECS has continued to see volume and price declines as the mining industry responds to the deteriorating outlook for commodities. ECS's trading in EMEA has also remained under pressure.

We continue to restructure and re-align our engineering, manufacturing and service capabilities to focus on segments of the conveyor market which value the efficiency improvements possible through adoption of our integrated solutions model. As part of this process, various resources, previously engaged on new customer capacity, are being re-focused on the aftermarket. In addition, the previously announced downsizing of ECS's UK workforce has been completed and similar measures were recently implemented in China.

Balance Sheet and Financing

During the period, the Group's net debt has remained in line with expectations, reflecting the increased focus on the Group's working capital. In addition, capital expenditure is being maintained within the range previously indicated.

Outlook

Leading indicators in the mining and energy industries are not yet showing any signs of recovery and we anticipate the recent challenging market conditions will continue. Nevertheless, we remain encouraged by the focussed way in which the ECS and oil and gas businesses are responding to cost management initiatives.

We expect the strong performance by the industrial, medical and other non-oil businesses within AEP to continue for the remainder of the year and we anticipate that, for AEP as a whole, the outcome for the year will be in line with previous management expectations.

However the recent developments in ECS's businesses will result in full year Group earnings, after recognising a lower tax rate, being slightly below previous management expectations.

Cash exceptional costs in the current financial year arising from our programme to restructure and refocus our business are expected to remain in line with previous guidance at below £10m.

--- ENDS ---

Analyst and Investor conference call

A conference call for analysts and investors will be held at 8:00 a.m. (UK time) today to discuss this statement. Participants can join the call on 020 3059 8125 (international dial-in + 44 20 3059 8125). A recording of this conference call will be available for 7 days on 0121 260 4861 (in the United States dial 1 866 268 1947 and in all other international locations dial + 44 121 260 4861) using the access code 1382682 followed by #; a replay facility will also be available through the company's web-site www.fenner.com.

For further information please contact:

Fenner PLC

 

Nicholas Hobson, Chief Executive OfficerJohn Pratt, Group Finance Director

01482 62650001482 626500

Weber Shandwick Financial

Nick Oborne

020 7067 0700

Notes to editors:

Fenner PLC is a world leader in reinforced polymer technology, providing local engineered solutions for performance-critical applications. The Group operates through two divisions:

Advanced Engineered Products: the AEP division uses advanced polymeric materials and technical expertise to provide high value-added solutions to customers' most challenging engineering problems. Customers are spread across a variety of end-user segments, including oil & gas, medical, construction, transportation, automation and general industrial. AEP's trading names are recognised globally and include CDI Energy Products, EGC Critical Components, Hallite, AIP Precision Machining, Fenner Precision, Fenner Drives, James Dawson, Mandals, Secant Medical, Charter Medical and Xeridiem

Engineered Conveyor Solutions: the ECS division, trading under the Fenner Dunlop, Fenner and Dunlop brand names, is a recognised leader in the global conveying market. The division offers a unique, comprehensive suite of products and services, which serve the conveying needs of mining, power generation and bulk handling markets.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLTDEILFIE
Date   Source Headline
7th Jan 20119:20 amRNSHolding(s) in Company
6th Jan 201110:35 amRNSAnnual Information Update
23rd Dec 201012:58 pmRNSHolding(s) in Company
16th Dec 201012:09 pmRNSHolding(s) in Company
9th Dec 20104:01 pmRNSDocuments available for inspection & Notice of AGM
7th Dec 201011:41 amRNSHolding(s) in Company
6th Dec 20107:00 amRNSGroup Announcement
1st Dec 20107:00 amRNSCompletion of JV Arrangements with BBV
29th Nov 20109:56 amRNSDirector/PDMR Shareholding
10th Nov 20107:00 amRNSBoard Changes
10th Nov 20107:00 amRNSFinal Results
5th Nov 20107:00 amRNSAcquisition of BBV
13th Oct 20109:53 amRNSHolding(s) in Company
4th Oct 201012:00 pmRNSNotice of Results
4th Oct 201012:00 pmRNSInvestor Presentation
6th Sep 20107:00 amRNSPre-Close Trading Update
2nd Sep 20109:54 amRNSBlocklisting Interim Review
31st Aug 201010:14 amRNSDirector/PDMR Shareholding
12th Aug 20109:14 amRNSHolding(s) in Company
6th Aug 20102:38 pmRNSHolding(s) in Company
6th Aug 20109:00 amRNSHolding(s) in Company
29th Jul 201011:04 amRNSHolding(s) in Company
19th Jul 20107:00 amRNSInterim Management Statement
8th Jul 20107:00 amRNSAcquisition of MRI Manufacturing & Research, Inc
6th Jul 20109:17 amRNSHolding(s) in Company
18th Jun 20102:52 pmRNSHolding(s) in Company
17th Jun 20107:00 amRNSDirectorate Change
28th May 20109:51 amRNSTotal Voting Rights
12th May 201010:22 amRNSHolding(s) in Company
6th May 20103:51 pmRNSHolding(s) in Company
6th May 201012:36 pmRNSHolding(s) in Company
4th May 20102:59 pmRNSDirector/PDMR Shareholding
4th May 20102:57 pmRNSDirector/PDMR Shareholding
29th Apr 20107:00 amRNSDirector/PDMR Shareholding
28th Apr 20101:02 pmRNSResults of Placing
28th Apr 20107:01 amRNSPlacing of New Ordinary Shares
28th Apr 20107:00 amRNSHalf Year Results
16th Apr 201012:47 pmRNSHolding(s) in Company
8th Apr 20103:40 pmRNSHolding(s) in Company
19th Mar 20107:00 amRNSAppointment of Non-Executive Director
8th Mar 20107:00 amRNSPre-close Trading Update
3rd Mar 20109:19 amRNSBlocklisting Interim Review
13th Jan 20107:00 amRNSAGM and IMS
6th Jan 201010:19 amRNSAnnual Information Update
10th Dec 200911:46 amRNSDocuments available for inspection & Notice of AGM
4th Dec 20099:24 amRNSDirector/PDMR Shareholding
24th Nov 20099:59 amRNSDirector/PDMR Shareholding
18th Nov 20093:40 pmRNSHolding(s) in Company
11th Nov 20097:00 amRNSFinal Results
4th Nov 20093:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.